/biz/ - Business & Finance

ARAV is a stock I think is terrible and is worth shorting or buying puts. Yes, the puts are hilariously expensive on ARAV but thats because the company could very realistically go to ZERO in coming months.

The company is a shitty biotech cancer therapy company with a god awful balance sheet. Not going into the science of the company's drug, but its gonna fail.

The argument for buying ARAV puts is that you can prob see the stock straight to zero on a fail. Unless they start draining equity ATM asap (which dilutes the stock) they aren’t even really a reverse merger candidate as currently constructed.

The balance sheet is obviously terrible and the company's auditors have labeled ARAV as a "Going Concern" .

Which is a big skeleton in the closet.

Click. Clack. Clickety Clack.